The announcement from the 16th of August says it has advanced to being available under the APS (authorised prescriber scheme). It says that this is an advance beyond the SAS.
You're in the industry - the company has announced what it is doing and our poster has shared his experience.
Can you use your expertise to dig a little deeper and give us some insights into what's happening rather than trying to argue that you don't believe that it's happening?
LTP Price at posting:
$1.79 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)